Gould V E, Koukoulis G K, Virtanen I
Department of Pathology, Rush Medical College, Chicago, IL 60612-3684.
Cell Differ Dev. 1990 Dec 2;32(3):409-16. doi: 10.1016/0922-3371(90)90057-4.
We studied by immunohistochemistry, the distribution of tenascin (Ten), cellular fibronectin (cFn), laminin and certain pertinent extracellular matrix protein receptors in normal human female breast, variants of fibrocystic disease (FCD), benign tumors, and ductal and lobular carcinomas. Monoclonal antibodies (mAb) to Ten, extradomain A containing cFn (EDAcFn), A and B chains of laminin, and beta-1 (beta-1) and different alpha subunits of intergrins were used. In in-situ ductal and lobular carcinomas, laminin staining had focal gaps, Ten-immunoreactivity displayed periductal or periacinar bands, and cFn showed broad and intense periductal staining; strong reactions for beta-1 and alpha-6 were noted in the basal cytoplasm of non-neoplastic myoepithelial cells while few tumor cells stained weakly. In infiltrating ductal and lobular carcinomas (IDC, ILC), laminin reactivity was weak, uneven or absent around neoplastic clusters whereas stromal staining for Ten and cFn was extensive and strong. In most IDC, moderate beta-1 and alpha-6 staining involved variable subpopulations; one mucinous carcinoma stained strongly and diffusely. In 20-40% of cells in ILC, beta-1 and alpha-6 were localized in delicate, ramified cytoplasmic processes. Indirect immunofluorescence studies with mAbs to other alpha-integrin subunits suggest that in various breast carcinomas only alpha-3 is expressed in tumor cells and that the vessels contained alpha-1 integrin. As compared with the normal breast, FCD and benign tumors, reactivity for Ten and cFn is increased in breast carcinomas while laminin is attenuated and decreased or absent; yet, Ten cannot be regarded as a carcinoma marker since it can be detected in benign tumors, FCD, and even in the normal breast.(ABSTRACT TRUNCATED AT 250 WORDS)
我们通过免疫组织化学研究了腱生蛋白(Ten)、细胞纤连蛋白(cFn)、层粘连蛋白及某些相关细胞外基质蛋白受体在正常女性乳腺、纤维囊性疾病(FCD)变体、良性肿瘤以及导管癌和小叶癌中的分布情况。使用了针对Ten、含cFn的结构域外A(EDAcFn)、层粘连蛋白的A链和B链以及整合素的β-1(β-1)和不同α亚基的单克隆抗体(mAb)。在原位导管癌和小叶癌中,层粘连蛋白染色有局灶性间隙,Ten免疫反应性显示为导管周围或腺泡周围带,cFn显示广泛且强烈的导管周围染色;在非肿瘤性肌上皮细胞的基底细胞质中观察到β-1和α-6的强反应,而少数肿瘤细胞染色较弱。在浸润性导管癌和小叶癌(IDC、ILC)中,肿瘤细胞簇周围的层粘连蛋白反应性弱、不均匀或缺失,而Ten和cFn的间质染色广泛且强烈。在大多数IDC中,中等强度的β-1和α-6染色涉及不同亚群;一例黏液腺癌染色强烈且弥漫。在ILC的20%-40%的细胞中,β-1和α-6定位于纤细的、分支状的细胞质突起中。用针对其他α整合素亚基的mAb进行的间接免疫荧光研究表明,在各种乳腺癌中,只有α-3在肿瘤细胞中表达,而血管含有α-1整合素。与正常乳腺、FCD和良性肿瘤相比,乳腺癌中Ten和cFn的反应性增加,而层粘连蛋白减弱、减少或缺失;然而,Ten不能被视为癌标志物,因为它可在良性肿瘤、FCD甚至正常乳腺中检测到。(摘要截断于250字)